FDA
Lamivudine and Zidovudine
The FDA lists this product in 13 strengths and forms.
Composition
- Active ingredients
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA077558-001 · Prescription
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA079124-001 · Prescription
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA090246-001 · Discontinued
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA206375-001 · Prescription
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA079079-001 · Discontinued
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA079081-001 · Discontinued
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA079128-001 · Prescription
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA090679-001 · Prescription
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA202418-001 · Discontinued
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA077411-001 · Prescription
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · Tablet
At a glance
- Brand name
- Lamivudine and Zidovudine
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Pharmacare
- Status
- Discontinued
- FDA approval
- 17 Mar 2017
- Application
- NDA022018-001